Competitive Pricing DeteriorationAnalyst notes deterioration in the company's price position relative to competitors, weakening price competitiveness and raising the risk of market share erosion.
GLP-1 Drug Impact On DemandAnalyst views rapid uptake of GLP-1 weight-loss drugs as a structural headwind that reduces demand for savoury, high-calorie items central to the business, weighing on sales and margins.
Volume Decline And Consumer WeaknessA prolonged slowdown pushed volumes into negative territory, with weather and softer consumer spending not fully explaining the decline and increasing downside risk to sales.